Posted by SandyWeb on October 23, 2003, at 11:32:49
DISCONTINUATION OF SALES OF NEFAZODONE IN CANADA
It has come to the attention of Health Canada that nefazodone has been associated with adverse hepatic events including liver failure requiring transplantation in Canada.
Following discussions with Health Canada, Bristol-Myers Squibb Canada has decided to discontinue sales of nefazodone, effective November 27, 2003.
During this transitional period, healthcare providers are asked to arrange alternative therapies other than nefazodone for their patients.
http://www.hc-sc.gc.ca/hpfb-dgpsa/tpd-dpt/bms_nefazodone_2_hpc_e.html
poster:SandyWeb
thread:272296
URL: http://www.dr-bob.org/babble/20031021/msgs/272296.html